三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
BL-B01D1:2L+非经典突变NSCLC的疗效(Her2突变人群非头对头对比德曲妥珠单抗)
BL-B01D1:2L+非经典突变NSCLC的疗效(Her2突变人群非头对头对比德曲妥珠单抗)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:76KB
图片尺寸:1819*495
同报告图片
/
4
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
所属报告:
医药健康行业专题研究:2025 ASCO (一)国产双抗ADC剑指FICBIC有望成难治肿瘤新解-250602(14页).pdf
打包全文图表
相关数据
ADC联合IO单抗治疗一线NSCLC全球三期研究启动时间
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
收藏
行业数据
2026-07-14
原图定位
查看详情
KRASG12C一线治疗NSCLC竞争格局(截至2026-6-25)
收藏
竞争格局
2026-07-01
原图定位
查看详情
全球KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
中国KRASG12C突变的NSCLC发病人数
收藏
行业数据
2026-07-01
原图定位
查看详情
SHR-A2009用于EGFR突变型NSCLC的1期临床研究结果
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
收藏
行业数据
2026-05-28
原图定位
查看详情
瑞康曲妥珠单抗与德曲妥珠单抗2LNSCLC适应症和数据对比(非头对头)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
瑞康曲妥珠单抗销售预测(仅限肺癌适应症)
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
收藏
行业数据
2026-05-28
原图定位
查看详情
SHR-A2009用于一线NSCLC患者的研究结果
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
收藏
行业数据
2026-05-28
原图定位
查看详情
瑞康曲妥珠单抗与德曲妥珠单抗2LNSCLC适应症和数据对比(非头对头)
收藏
行业数据
2026-04-20
原图定位
查看详情
瑞康曲妥珠单抗在研适应症(截至2026年2月)
收藏
行业数据
2026-04-20
原图定位
查看详情
PD(L)1*VEGF双抗单药针对一线NSCLC数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
各药物针对IO耐药NSCLC临床数据汇总
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
收藏
行业数据
2026-03-13
原图定位
查看详情
驱动基因阴性晚期NSCLC治疗格局
收藏
竞争格局
2026-02-24
原图定位
查看详情
NSCLC1L全球竞争格局AK112BNT327707
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
收藏
竞争格局
2026-01-28
原图定位
查看详情
全球TROP2/HER3靶点创新管线临床布局(截至2025.12)
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
收藏
行业数据
2025-12-31
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
BL-B01D1 非经典突变 NSCLC 疗效验证,有望成为肺癌治疗基石 在 BL-B01D1-101 研究中 BL-B01D1 单药治疗 SoC 耐药且具有经典 EGFR 突变之外驱动 突变的 NS CLC 的数据入选口头汇报。该部分研究纳入了 EGFR Ex20ins、非经典 EGFR 突变、HER2、ALK、ROS1、BRAF(V600E 等)、KRAS(G12C 等)、SMARCA4、MET(Ex14 跳突等)、RET 和 NTRK 突变。68 例可评估患者的 ORR/DCR 为 45.6/82.4%,PFS达 6.7个月。在EGFR Ex20ins及其他EGFR非经典突变患者中的ORR/DCR为 75/100%,PFS 未达到;HER2 突变患者中的 ORR/DCR 为 61.5/100%,PFS 为 8.4 月,非头对头比较优于德曲妥珠单抗。同时该研究报道了与既往报道近似的良好安全性数据,主要 3 级及以上 TRAE 为血液学毒性,研究中仅发生 1 例 2 级 ILD,且仅有 2.7%患者因 TRAEs 停药。该研究补齐了 BL-B01D1 在 NSCLC 经典 EGFR 突变之外驱动突变患者中的疗效证据,有
行业数据
原图定位
当前图表所属:
医药健康行业专题研究:2025 ASCO (一)国产双抗ADC剑指FICBIC有望成难治肿瘤新解-250602(14页).pdf
2025年ASCO国产创新药报告:双抗ADC突破难治肿瘤,胰腺癌SCLC疗效BIC潜力
BL-B01D1vs竞品:PD-(L)1耐药SCLC临床数据比较简
ZG006vstarlatamab:2L+SCLC临床数据比较简
IBI343vs同靶点竞品:治疗2L+PDAC的临床数据比较简
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》